ARCHIVES

Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program

This article is from The Cancer Letter archive.

Vol. 05 No. 12 | March 23, 1979

Download PDF Visit The Full Archive

Related Articles

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

Medicare: Clinton Budget Revives Proposal To End Physician Drug Markup

February 6, 1998

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989